Skip to main content



) --

Techne Corporation



) hit a new 52-week high Monday as it traded at $73 compared with its previous 52-Week high of $72.71. Techne is changing hands at $72.46 with 4,913 shares traded as of 9:31 a.m. ET. Average volume has been 106,900 shares over the past 30 days.

Techne has a market cap of $2.6 billion and is part of the

health care

sector and


TheStreet Recommends

industry. Shares are up 9% year to date as of the close of trading on Friday.

TECHNE Corporation and its subsidiaries engage in the development, manufacture, and sale of biotechnology products, and hematology calibrators and controls primarily in the United States and Europe. The company has a P/E ratio of 23.5, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 22.6.

TheStreet Ratings rates Techne as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full

Techne Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center